Results 71 to 80 of about 12,760 (216)

Vaginal‐Derived Potential Probiotics and Their Postbiotics Alleviate Aerobic Vaginitis via Suppressing TLR4/MyD88/NF‐κB Signalling Pathway and Potentially Enhancing Vaginal Barrier

open access: yesMicrobial Biotechnology, Volume 19, Issue 3, March 2026.
Consolidated diagram of the mechanism by which L. crispatus YBR‐01, L. plantarum YBR‐01, and their postbiotics improve AV progression. ABSTRACT Antibiotic therapy is currently challenged by drug resistance and high recurrence in aerobic vaginitis (AV), making it urgent to seek novel strategies. In this study, we selected two potential probiotic strains
Meiyun Tian   +7 more
wiley   +1 more source

Vulvovaginal candidiasis [PDF]

open access: yesInternational Journal of Gynecology & Obstetrics, 2006
D, Moreira, C R, Paula
openaire   +4 more sources

Treatment of recurrent vulvovaginal candidiasis in women planning a pregnancy [PDF]

open access: yesРМЖ. Мать и дитя, 2018
Treatment of recurrent vulvovaginal candidiasis in women planning a pregnancy Borovikov I.O., Kutsenko I.I., Gerasimenko E.E. Kuban State Medical University, Krasnodar Aim: evaluation of treatment methods for recurrent vulvovaginal candidiasis ...
Borovikov I.O.   +2 more
doaj  

How should you treat Candida vaginitis in patients on antibiotics? [PDF]

open access: yes, 2007
Oral and intravaginal antifungals for the treatment of uncomplicated vulvovaginal candidiasis (VVC) have similar effectiveness (strength of recommendation [SOR]: A, systematic review).
Hitchcock, Kristin   +2 more
core  

Research Progress in the Treatment of Vaginitis With Bioactive Compounds: Targeting of Vaginal Microflora

open access: yesMicrobiologyOpen, Volume 15, Issue 1, February 2026.
Mechanism diagram of the effect of herbal medicine on vaginitis. Herbal medicines mainly combat vaginitis by (A) inhibiting bacteria, (B) inhibiting fungi, (C) acting on the cilia of Trichomonas, (D) inhibiting virus replication, (E) repairing the mucosa, (F) enhancing immunity, and (G) maintaining the microecological balance.
Yongming Li   +4 more
wiley   +1 more source

Vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis [PDF]

open access: yes
Background: Vulvovaginal candidiasis (VVC) is a fungal infection of the vagina and vulva. It is usually caused by Candida albicans, however, occasionally other candida species are responsible. The optimal treatment of VVC has not yet been defined.
تلو, مهشید   +3 more
core  

Hubungan Antara Terjadinya Kandidiasis Vulvovaginalis Dengan Penggunaan Kontrasepsi Hormonal [PDF]

open access: yes, 2016
Latar belakang: Kandidiasis vulvovaginalis (KVV) merupakan infeksi pada vulva dan/atau vagina dikarenakan pertumbuhan yang tidak terkendali dari jamur Candida sp., terutama Candida albicans.
Armalina, D. (Desy)   +2 more
core   +1 more source

Probiotic‐Based Materials as Living Therapeutics

open access: yesAdvanced Materials, Volume 38, Issue 1, 2 January 2026.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio   +2 more
wiley   +1 more source

Serious fungal infections in the Philippines [PDF]

open access: yes, 2017
The Philippines is a low middle-income, tropical country in Southeast Asia. Infectious diseases remain the main causes of morbidity, including tuberculosis. AIDS/HIV prevalence is still low at <1%, but is rapidly increasing.
D. Denning, M. C. R. Batac
core   +1 more source

Antifungal Nanoparticles in Microbial Biotechnology: Multisector Mechanisms, Applications, and Future Frontiers

open access: yesIET Nanobiotechnology, Volume 2026, Issue 1, 2026.
Fungal pathogens threaten global food security, ecosystem stability, and human health, while the overuse of conventional fungicides accelerates resistance and disrupts beneficial microbiota. Nanotechnology offers a powerful new paradigm for fungal control, but its greatest potential lies at the interface with microbial biotechnology.
Kaveh Rahimi Mamaghani   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy